Showing Results for: “Glycemic Index and Diabetes”

New Platform will Empower the 30 Million Americans with Diabetes to Advocate for Legislation that Promotes Insulin and Drug Affordability The American Diabetes Association (ADA) has created a free Communications & Engagement Platform to demystify the political rhetoric of drug pricing policy for the diabetes community. In keeping with ADA’s commitment to help those living with diabetes thrive, this platform will enable people with diabetes, their families and their health care providers to easily understand the legislative options on the table using three simple questions. It is critical that

The first sub-analysis of renal data from the Dapagliflozin Effect on Cardiovascular Events Thrombolysis In Myocardial Infarction (DECLARE-TIMI 58) trial indicates that dapagliflozin, an oral sodium glucose cotransporter 2 (SGLT2) inhibitor, reduced the progression of kidney disease or renal death in patients with type 2 diabetes (T2D). The initial results from the trial, the first cardiovascular outcome study to enroll a large cohort of patients with diabetes risk factors for Atherosclerotic Cardiovascular Disease (ASCVD) and a large number of patients with diabetes with known ASCVD, were

For 70 years, the American Diabetes Association (ADA) has hosted summer camps for children and teens with type 1 diabetes. In 2019 nearly 7,000 campers, their siblings, and children at-risk of type 2 diabetes, ages 4-17, will attend one of 80 camp sessions nationwide and enjoy a traditional summer camp experience in a medically-safe environment. ADA Camps create opportunities for campers to build life-long friendships, overcome feelings of isolation, and become empowered to manage their diabetes. Additionally, campers participate in physical activity and receive individualized dietary

CEO Tracey D. Brown Calls on Congress to Take Aggressive Steps to Make Insulin and Other Diabetes Medications More Affordable The American Diabetes Association® (ADA) last week recommended urgent federal action to bring down skyrocketing drug prices before the Senate Health, Education, Labor and Pensions (HELP) Committee. In a statement for the congressional record submitted in conjunction with the HELP Committee’s Primary Health and Retirement Security Subcommittee’s recent hearing exploring reasons the U.S. pays the highest prices in the world for prescription medications, ADA CEO Tracey D

Last night Congress took an important step toward COVID-19 management and recovery, addressing health disparities and funding crucial diabetes research programs. The diabetes community has been disproportionately affected by this pandemic, and the American Diabetes Association® (ADA) is pleased that Americans with diabetes will soon see some relief during these difficult and extraordinary times. Although there’s still much more to be done to support those facing a heightened risk during this unprecedented public health and economic crisis – including ensuring continuity of health insurance

Keeping our young people healthy and active amid coronavirus related closures is essential, and while organizations continue to scramble and pivot, the American Diabetes Association® (ADA) has transformed Project Power virtually. Project Power is a free at-home online experience consisting of fun lessons and physical activity challenges, which encourages children and families to stay healthy together. Nearly 1 in 3 children in the United States are overweight or obese. Through the initiative, the ADA intends to slow the trajectory of childhood obesity by focusing on health promotion, nutrition

Waters Bill Would Eliminate Cost-Sharing for Insulin-Dependent Seniors The American Diabetes Association (ADA), announced its strong support today for the Affordable Insulin for the COVID-19 Emergency Act, introduced by Representative Maxine Waters (D-CA-43). The ADA called on all Members of Congress to join the measure’s 25 original co-sponsors. The bill ensures that insulin-dependent Medicare beneficiaries are able to obtain their prescriptions for insulin and associated medical supplies with no copayments, coinsurance, deductibles or other cost-sharing for the duration of the COVID-19

The American Heart Association and the American Diabetes Association share inspiration from patients and need-to-know information from experts As emerging science around COVID-19 highlights elevated danger for people with diabetes, heart disease and stroke 1 , the American Heart Association and the American Diabetes Association urge people living with type 2 diabetes and/or cardiovascular disease to manage their conditions and look for unique opportunities to double-down on their health goals during the pandemic. Brandon Lewis of Dallas lives with diabetes, and now is dealing with being at

Eager to repeat the successes of last year's partnership, GNC, the global leader in health and wellness, and the American Diabetes Association ® (ADA) have once again teamed up to launch a national fundraising campaign aimed to support the over 38 million Americans living with diabetes and the millions more at risk. GNC customers can now participate by making donations at their local GNC store or online, with options to round up their purchase to the nearest dollar or select a donation amount of their choice. All proceeds will directly benefit the ADA, supporting their crucial work in diabetes

As part of the Biden administration’s plan to review Trump executive actions on health care, the U.S. Department of Health and Human Services (HHS) announced a delay in implementation of the “rebate rule,” moving the effective date from January 1, 2022, to January 1, 2023. The Trump administration announced its rebate proposal in 2018. The proposed rule would have effectively banned the rebates drug manufacturers give to pharmacy benefit managers in Medicare Part D—Medicare’s prescription drug program—only allowing rebates at the point of sale in an effort to reduce patients’ out-of-pocket